---
ID: "c20e860d-13f8-4b95-8551-aa8b264fdf56"
Parent: "224988de-fb98-488b-b34a-b17e308796e0"
Template: "e269fbb5-3750-427a-9149-7aa950b49301"
Path: /sitecore/templates/Project/Perskindol/Datasources/News/News Detail/Content
Languages:
- Language: en
  Versions:
  - Version: 1
    Fields:
    - ID: "25bed78c-4957-4165-998a-ca1b52f67497"
      Hint: __Created
      Value: 20231106T050108Z
    - ID: "52807595-0f8f-4b20-8d2a-cb71d28c6103"
      Hint: __Owner
      Value: |
        sitecore\dpham@zuelligpharma.com
    - ID: "5dd74568-4d4b-44c1-b513-0af5f4cda34f"
      Hint: __Created by
      Value: |
        sitecore\dpham@zuelligpharma.com
    - ID: "8cdc337e-a112-42fb-bbb4-4143751e123f"
      Hint: __Revision
      Value: "a89d8530-7c5b-44f6-b3fa-05830043d99d"
    - ID: "badd9cf9-53e0-4d0c-bcc0-2d784c282f6a"
      Hint: __Updated by
      Value: |
        sitecore\ngunguyen@zuelligpharma.com
    - ID: "d9cf14b1-fa16-4ba6-9288-e8a174d4d522"
      Hint: __Updated
      Value: 20231115T041206Z
- Language: "ko-KR"
  Versions:
  - Version: 1
    Fields:
    - ID: "25bed78c-4957-4165-998a-ca1b52f67497"
      Hint: __Created
      Value: 20231108T031617Z
    - ID: "5dd74568-4d4b-44c1-b513-0af5f4cda34f"
      Hint: __Created by
      Value: |
        sitecore\dpham@zuelligpharma.com
    - ID: "8cdc337e-a112-42fb-bbb4-4143751e123f"
      Hint: __Revision
      Value: "e6006149-1a01-4f2c-8578-99b1426c5066"
    - ID: "badd9cf9-53e0-4d0c-bcc0-2d784c282f6a"
      Hint: __Updated by
      Value: |
        sitecore\dpham@zuelligpharma.com
    - ID: "d9cf14b1-fa16-4ba6-9288-e8a174d4d522"
      Hint: __Updated
      Value: 20231108T031617Z
